Blockade of the passive cell death pathway does not prevent tolerance induction to islet grafts

Transplantation

Volumn 83, Issue 5, 2007, Pages 653-655

  Lehnert, Anne M ^a   Murray Segal, Lisa ^b   Cowan, Peter J ^b   D'Apice, Anthony J ^b   O'Connell, Philip J ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Apoptosis; Bim; Costimulation blockade; Islet transplantation; Tolerance

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN BCL 2;

ALLOGRAFT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; GRAFT SURVIVAL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE; WILD TYPE; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL DEATH; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOCONJUGATES; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS;

EID: 33947309701     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000255592.09784.ba     Document Type: Article

References (14)

1. Zheng XX, Sancho-Fueyo A, Domenig C, Strom TB. The balance of deletion and regulation in allograft tolerance. Immunol Rev 2003; 196: 75.
2. Li Y LX, Zheng XX, Wells AD, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5: 1298.
3. Wells AD LX, Li Y, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303.
4. Kishimoto K SS, Imitola J, Sho M, et al. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest 2002; 109: 1471.
5. Zheng XX, Sancho-Fueyo A, Sho M, et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003; 19: 503.
6. Lehnert AM YS, Burgess JS, O'Connell PJ. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation. Transplantation 2000; 69: 1176.
7. Strasser A HA, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889.
8. Bouillet P, Huang DC, Tarlinton DM, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735.
9. Chandra AP SE, Walters SN, Murray-Segal L, et al. Fate of alphaGal +/+ pancreatic islet grafts after transplantation into alphaGal knockout mice. Xenotransplantation 2004; 11: 323.
10. Noelle RJ RM, Shepherd DM, Stamenkovic I, et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Nat Acad Sci USA 1992; 89: 6550.
11. Tran HM NP, Restifo AC, Ivis-Woodward MA, et al. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J Immunol 1997; 159: 2232.
12. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440.
13. Vaux DL, Aguila HL, Weissman IL. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int Immunol 1992; 4: 821.
14. Monk NJ HR, Marsh JE, Farrar CA, et al. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med 2003; 9: 1259.